Wed, July 20, 2016
Tue, July 19, 2016
Mon, July 18, 2016
Fri, July 15, 2016
Thu, July 14, 2016

David Amsellem Downgraded (SUPN) to Hold on, Jul 18th, 2016

David Amsellem of Piper Sandler, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold on, Jul 18th, 2016.

David has made no other calls on SUPN in the last 4 months.



There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • David Steinberg of "Jefferies" Maintained at Strong Buy with Increased Target to $23 on, Thursday, May 12th, 2016